# Characterization of Patients With Tuberous Sclerosis Complex, Lymphangioleiomyomatosis and Angiomyolipoma

> **NCT02325505** · — · COMPLETED · sponsor: **InCor Heart Institute** · enrollment: 200 (actual)

## Conditions studied

- Tuberous Sclerosis
- Lymphangioleiomyomatosis
- Angiomyolipoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02325505
- **Lead sponsor:** InCor Heart Institute
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-04
- **Primary completion:** 2021-04
- **Final completion:** 2022-08
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2022-08-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02325505

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02325505, "Characterization of Patients With Tuberous Sclerosis Complex, Lymphangioleiomyomatosis and Angiomyolipoma". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02325505. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*